๐Ÿ‡บ๐Ÿ‡ธ FDA

Intelligence ยท Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors โ€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ€” searchable for business development and competitive intelligence.

6,867 results for โ€œDeโ€ Clear

  1. Lanadelumab

    Takeda

    Hereditary Angioedema

    phase 3 small molecule completed

    1 trial

  2. Lanadelumab

    Takeda

    Hereditary Angioedema (HAE)

    phase 3 small molecule completed

    2 trials

  3. Lanadelumab

    Takeda

    Angioedema

    phase 3 small molecule completed

    2 trials

  4. Lantus SoloStar 100 units/ml solution for injection in a pre-filled pen, insulin icodec 700 U/mL PDS290

    NovoThirteen

    Type 2 Diabetes

    phase 3 small molecule active

    1 trial

  5. Lapaquistat Acetate

    Takeda

    Dyslipidemia

    phase 3 small molecule completed

    2 trials

  6. Lebrikizumab

    Eli Lilly and Company

    Atopic Dermatitis

    phase 3 mab completed

    1 trial

  7. Lecanemab

    Eisai Co.,

    Mild cognitive impairment due to Alzheimer's disease or mild Alzheimer's disease dementia.

    phase 3 small molecule active

    1 trial

  8. Leflunomide Mylan 10 mg, filmomhulde tabletten, PLACEBO

    Disc Medicine

    polymyalgia rheumatica

    phase 3 small molecule active

    1 trial

  9. Lenabasum 20 mg

    Corbus Pharmaceuticals Holdings

    Dermatomyositis

    phase 3 small molecule completed

    1 trial

  10. Lenalidomide

    Celgene Europe Limited

    B-cell Chronic Lymphocytic Leukemia

    phase 3 small molecule completed

    1 trial

  11. Lenvatinib, Belzutifan, Lenvatinib

    Merck Sharp and Dohme

    Renal Cell Carcinoma, hepatocellular carcinoma, nonMSI-H/dMMR colorectal cancer, pancreatic ductal adenocarcinoma, biliary tract cancer, non-MSIH/dMMR endometrial cancer, esophageal squamous cell carcinoma, Advanced Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, von Hippel-Lindau (VHL)Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor, Advanced Solid Tumors With HIF-2ฮฑ related Genetic Alterations

    phase 3 small molecule active

    1 trial

  12. Levamlodipine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension

    phase 3 small molecule completed

    1 trial

  13. Levetiracetam XR, Masked Keppraยฎ placebo film-coated tablets (a placebo tablet inside a capsule), Keppra 500 mg film-coated tablets, Levetiracetam prolonged-release placebo granules

    NEURAXPHARM AUSTRALIA PTY LIMITED

    Refractory Partial Onset Epilepsy

    phase 3 small molecule active

    1 trial

  14. Levodopa

    Lxo Ireland Designated Activity Company

    Ischaemic Stroke

    phase 3 small molecule completed

    1 trial

  15. Levonorgestrel 100 mcg and Ethinyl Estradiol 20 mcg

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oral Contraceptive

    phase 3 small molecule active

    1 trial

  16. Libmeldy 2-10 x 10^6 cells/mL dispersion for infusion

    Orchard Therapeutics (Netherlands) B.V.

    Metachromatic Leukodystrophy (MLD) is an autosomal recessive disorder caused by mutations

    phase 3 small molecule active

    1 trial

  17. Linaclotide

    IRONWOOD PHARMACEUTICALS INC

    Chronic Constipation

    phase 3 small molecule completed

    1 trial

  18. Linaclotide

    IRONWOOD PHARMACEUTICALS INC

    Functional Constipation

    phase 3 small molecule completed

    3 trials

  19. Linaclotide

    IRONWOOD PHARMACEUTICALS INC

    Chronic Idiopathic Constipation

    phase 3 small molecule completed

    1 trial

  20. Linaclotide 290 micrograms

    IRONWOOD PHARMACEUTICALS INC

    Irritable Bowel Syndrome Characterized by Constipation

    phase 3 small molecule completed

    1 trial

  21. Linaclotide 290 micrograms

    IRONWOOD PHARMACEUTICALS INC

    Chronic Constipation

    phase 3 small molecule completed

    2 trials

  22. Linaclotide or Matching Placebo

    IRONWOOD PHARMACEUTICALS INC

    Irritable Bowel Syndrome With Constipation

    phase 3 small molecule completed

    1 trial

  23. Linvoseltamab

    Regeneron UK Limited

    High Risk Smoldering Multiple Myeloma (HR-SMM)

    phase 3 small molecule active

    1 trial

  24. Lipid-lowing Tea

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hyperlipidemia

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1โ€“3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources